Vaxart, Inc. Marketable Securities (Current)
Vaxart, Inc. (VXRT) had Marketable Securities (Current) of $2.08 million as of 2011-12-31, per its 10-Q filed 2012-11-08.
Discontinued › Balance Sheet › Assets › Assets, Current › Cash, Cash Equivalents, and Short-Term Investments
us-gaap:MarketableSecuritiesCurrent · last filed 2012-11-08
- 2011-12-31: Marketable Securities, Current $2.08M.
- 2011-09-24: Marketable Securities, Current $9.06M.
- 2011-06-25: Marketable Securities, Current $15.71M.
- 2010-12-25: Marketable Securities, Current $54.60M.
| Period end | Marketable Securities, Current |
|---|---|
| 2011-12-31 | $2.08M 10-Q · filed 2012-11-08 |
| 2011-09-24 | $9.06M 10-Q · filed 2011-11-02 |
| 2011-06-25 | $15.71M 10-Q · filed 2011-08-03 |
| 2010-12-25 | $54.60M 10-K · filed 2012-03-14 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Kalaris Therapeutics, Inc. (KLRS) | United States | $0.073B | -2.19 |
| Atara Biotherapeutics, Inc. (ATRA) | United States | $0.086B | -6.48 |
| Pelthos Therapeutics Inc. (PTHS) | United States | $0.086B | -1.20 |
| CHAMPIONS ONCOLOGY, INC. (CSBR) | United States | $0.070B | -68.02 |
| COGNITION THERAPEUTICS INC (CGTX) | United States | $0.090B | -6.52 |
| BioStem Technologies, Inc. (BSEM) | United States | $0.069B | |
| Eloxx Pharmaceuticals, Inc. (ELOX) | United States | $0.065B | |
| MiNK Therapeutics, Inc. (INKT) | United States | $0.063B | -5.37 |
| Cardiff Oncology, Inc. (CRDF) | United States | $0.101B | -2.22 |
| EXOZYMES INC. (EXOZ) | United States | $0.058B |